About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT03368612

Comparative Study Between the AirGoTM System and Standard Tests in the Assessment of the Respiratory Function

The study aims at evaluating the AirGoTM system's performance, as compared to standard pulmonary function tests.

Lead sponsor: Ospedale Santa Croce-Carle Cuneo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

ANDREA ANTONELLI, MD

CONTACT

+39017161 ANTONELLI.A@OSPEDALE.CUNEO.IT

ALESSIA STANZI, MD

CONTACT

+39017161 STANZI.A@OSPEDALE.CUNEO.IT

Sponsors

Lead Sponsor

Ospedale Santa Croce-Carle Cuneo

Primary endpoint: • To test the AirGoTM system's respiratory rate recording accuracy at rest and during physical exercise, as compared to standard tests. Secondary endpoints: * To test the accuracy of the AirGoTM system's derived respiratory parameters (tidal volume, minute ventilation, Tiffeneau-Pinelli index, FEV1 and VO2max) at rest and during physical exercise, as compared to standard tests. * To test comfort and subjects' compliance with the AirGoTM system during long term recording (24 hours).

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Non-smoker healthy volunteers,
•Able to perform a routine respiratory function test (spirometry and cardiopulmonary exercise testing),
•aged between 18 and 75 years,
•who signed a written informed consent.

Exclusion Criteria

•Present cardiac comorbidities (eg. coronary artery disease, heart failure, arrhythmias);
•History of coronary artery disease or heart failure;
•Respiratory comorbidities (eg. asthma, chronic obstructive disease, sleep apnoea, lung interstitial disease);
•Pregnancy;
•Former smoker of \>5 p/y;
•Severe trauma or major surgery in the last year;
•Chest pain;
•Obesity (BMI \>30).

Related studies

Enrolling By InvitationNA

Respiratory Monitoring System That Detects & Predicts OIRD

NCT07217197 · Respiration Disorders

Not Yet RecruitingNA

Continuous Sedation vs Daily Sedation Interruption in Ventilated Children

NCT07438834 · Pneumonia, Respiration Disorders

Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère

NCT03339817 · Multiple Sclerosis, Respiration Disorders

COMPLETEDPhase 2

Daily Vitamin D for Sickle-cell Respiratory Complications

NCT04170348 · Sickle Cell Disease, Anemia, Sickle Cell, and more

Non-invasive Methods of Measuring Lung Volume

NCT06681467 · Respiration Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 11, 2017Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateSep 2017

Last updatedDec 11, 2017

Condition

Respiration Disorders

Locations shown

A.O. S. Croce E Carle Di Cuneo

Cuneo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 11, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions